Penicillin Allergy: Challenge and Delabelling
Contraindications:
- Patient clinically unstable
- Pregnant patients
- Uncontrolled asthma
- Unstable Ischemic Heart Disease (IHD)
Discuss delabelling with patient/Power of Attorney (PoA). If patient/PoA consents, document the consent in patient’s EPR record and proceed with delabelling.
Documenting outcome of penicillin challenge and delabelling
- Modify allergy status on secondary care/primary care notes
- If allergy disproven, state “Successfully delabelled DD/MM/YYYY: Patient is NOT penicillin-allergic”
- If allergy confirmed, state “Penicillin allergy CONFIRMED on DD/MM/YYYY– symptoms of XXX”
Inform the patient the outcome of the challenge. If the allergy has been disproved then counsel the patient that they are no longer allergic to penicillins based on your assessment +/- results of challenge.
References
- Mirakian R, Leech SC, Krishna MT, et al. Management of allergy to penicillins and other beta-lactams. Clin Exp Allergy. 2015;45(2):300-327. doi:10.1111/cea.12468
- BSACI guideline for the set-up of penicillin allergy de-labelling services by non-allergists working in a hospital setting. Clin Exp Allergy. 2022; 52: 1135-1141. doi: 10.1111/cea.14217
-
Krishna, M.T. et al. A multicentre observational study to investigate feasibility of a direct oral penicillin challenge in de-labelling ‘low risk’ patients with penicillin allergy by non-allergy healthcare professionals (SPACE study): Implications for healthcare systems. Journal of infection. 2023;88(3). doi: 10.1016/j.jinf.2024.01.015